Fadell Nicholas, Jeong Daehee, Iskeirjeh Sara, Muneer Mohammed, Farsakoury Rana, Alyazji Zaki, Aljassem Ghanem, Braizat Omar, Skolnick Gary B, Sacks Justin M, Glass Graeme E, Badran Saif M
Division of Plastic and Reconstructive Surgery, Department of Surgery, Washington University School of Medicine, St. Louis, MO, USA.
College of Medicine and Public Health, Flinders University, Adelaide, Australia.
Aesthetic Plast Surg. 2025 Aug;49(15):4350-4358. doi: 10.1007/s00266-025-04975-w. Epub 2025 Jun 2.
Despite the current increase in body contouring surgery (BCS), the impact of preoperative chemoprophylaxis on bleeding after BCS remains undetermined.
A single institution retrospective cohort study examined patients undergoing abdominal BCS (abdominoplasty, lower body lift, and/or liposuction). Outcomes included estimated blood loss (EBL), hemoglobin drop on the first post-operative day, drain output, length of hospital stay, and the need for surgical evacuation of hematoma or transfusion. Statistical tests performed included chi-square, Wilcoxon signed-rank, and linear regressions using R.
Of the 697 patients, 136 (19.5%) received no anticoagulation, 324 (46.5%) had preoperative anticoagulation, 209 (29.9%) received both preoperative and postoperative anticoagulation, and 28 (4%) had missing data. Preoperative LMWH was linked to a 45% increase in serosanguinous drain output on day one (145 ml vs. 100 ml; p < 0.001) but did not increase bleeding risk. Male patients had higher odds of hematoma (OR 14.8, p < 0.001), greater need for blood (OR 5.13, p < 0.001) or plasma (OR 6.15, p < 0.001) transfusion, more significant hemoglobin drop (- 2.23 +/- 1.06 g/dL vs. - 1.43 +/- 1.01 g/dL, p < 0.001), and higher drain output on day one (180 mL vs. 130 mL, p < 0.001) and overall (655 mL vs. 380 mL, p < 0.001). Previous obesity surgery patients also had higher odds for hematoma (OR 3.24, p = 0.011), blood transfusion (OR 3.26, p = 0.002), and increased drain output.
Preoperative chemoprophylaxis in BCS is associated with increased serosanguinous drain output without additional bleeding risk. Male gender and a history of obesity surgery increase the risk of hematoma, hemoglobin drop, and transfusion needs.
This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine Ratings, please refer to Table of Contents or online Instructions to Authors www.springer.com/00266 .
尽管目前身体塑形手术(BCS)有所增加,但术前化学预防对BCS术后出血的影响仍未确定。
一项单机构回顾性队列研究对接受腹部BCS(腹壁成形术、下半身提升术和/或抽脂术)的患者进行了检查。结果包括估计失血量(EBL)、术后第一天血红蛋白下降情况、引流液量、住院时间以及手术清除血肿或输血的必要性。所进行的统计检验包括卡方检验、Wilcoxon符号秩检验以及使用R软件进行的线性回归分析。
在697例患者中,136例(19.5%)未接受抗凝治疗,324例(46.5%)进行了术前抗凝,209例(29.9%)接受了术前和术后抗凝,28例(4%)数据缺失。术前低分子肝素与第一天血清血性引流液量增加45%相关(145毫升对100毫升;p<0.001),但未增加出血风险。男性患者发生血肿的几率更高(OR 14.8,p<0.001),输血(OR 5.13,p<0.001)或输血浆(OR 6.15,p<0.001)的需求更大,血红蛋白下降更显著(-2.23±1.06克/分升对-1.43±1.01克/分升,p<0.001),第一天引流液量更高(180毫升对130毫升,p<0.001)且总体引流液量更高(655毫升对380毫升,p<0.001)。既往接受过肥胖手术的患者发生血肿(OR 3.24,p = 0.011)、输血(OR 3.26,p = 0.002)和引流液量增加的几率也更高。
BCS术前化学预防与血清血性引流液量增加相关,但无额外出血风险。男性和有肥胖手术史会增加血肿、血红蛋白下降和输血需求的风险。
证据级别III:本刊要求作者为每篇文章指定证据级别。有关这些循证医学评级的完整描述,请参阅目录或作者在线指南www.springer.com/00266 。